Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO
21 mars 2022 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl Iberger, Precipio’s CFO for the past five...
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
24 févr. 2022 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced its unaudited and preliminary results for 2021. The Company...
New York State Approves Precipio’s HemeScreen for POL clinical use
18 nov. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
Precipio Announces Q3-2021 and year-end Shareholder Update Call
01 nov. 2021 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM...
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
26 août 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
Precipio Reschedules Q2-2021 Shareholder Update Call
20 août 2021 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to...
Precipio Corrects Announcement of Q2-2021 Shareholder Update Call
13 août 2021 10h48 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Q2-2021 and year-end Shareholder Update Call
12 août 2021 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
28 juil. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces preliminary unaudited revenues for Q2-2021 demonstrating continued...
Precipio Terminates its Equity Line
15 juin 2021 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 15, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces that as part of management’s review of its current financing arrangements,...